Cite

    Jarushka Naidoo et al.. “788 Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety and cerebrospinal fluid biomarkers.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A471–A472. http://access.bl.uk/ark:/81055/vdc_100144721123.0x000004